Hologic PE Ratio 2010-2025 | HOLX
Current and historical p/e ratio for Hologic (HOLX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hologic PE ratio as of August 12, 2025 is 16.38.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Hologic PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-12 | 67.95 | 28.20 | |
| 2025-06-30 | 65.16 | $2.41 | 27.04 |
| 2025-03-31 | 61.77 | $2.37 | 26.06 |
| 2024-12-31 | 72.09 | $3.17 | 22.74 |
| 2024-09-30 | 81.46 | $3.33 | 24.46 |
| 2024-06-30 | 74.25 | $2.94 | 25.26 |
| 2024-03-31 | 77.96 | $1.96 | 39.78 |
| 2023-12-31 | 71.45 | $2.11 | 33.86 |
| 2023-09-30 | 69.40 | $1.83 | 37.92 |
| 2023-06-30 | 80.97 | $1.93 | 41.95 |
| 2023-03-31 | 80.70 | $2.99 | 26.99 |
| 2022-12-31 | 74.81 | $3.92 | 19.08 |
| 2022-09-30 | 64.52 | $5.12 | 12.60 |
| 2022-06-30 | 69.30 | $5.93 | 11.69 |
| 2022-03-31 | 76.82 | $6.07 | 12.66 |
| 2021-12-31 | 76.56 | $6.65 | 11.51 |
| 2021-09-30 | 73.81 | $7.20 | 10.25 |
| 2021-06-30 | 66.72 | $7.80 | 8.55 |
| 2021-03-31 | 74.38 | $7.29 | 10.20 |
| 2020-12-31 | 72.83 | $5.27 | 13.82 |
| 2020-09-30 | 66.47 | $4.20 | 15.83 |
| 2020-06-30 | 57.00 | $2.47 | 23.08 |
| 2020-03-31 | 35.10 | $2.29 | 15.33 |
| 2019-12-31 | 52.21 | $0.92 | 56.75 |
| 2019-09-30 | 50.49 | $-0.15 | 0.00 |
| 2019-06-30 | 48.02 | $-0.12 | 0.00 |
| 2019-03-31 | 48.40 | $-0.06 | 0.00 |
| 2018-12-31 | 41.10 | $-1.51 | 0.00 |
| 2018-09-30 | 40.98 | $-0.42 | 0.00 |
| 2018-06-30 | 39.75 | $-0.31 | 0.00 |
| 2018-03-31 | 37.36 | $-0.51 | 0.00 |
| 2017-12-31 | 42.75 | $3.79 | 11.28 |
| 2017-09-30 | 36.69 | $2.64 | 13.90 |
| 2017-06-30 | 45.38 | $2.68 | 16.93 |
| 2017-03-31 | 42.55 | $2.77 | 15.36 |
| 2016-12-31 | 40.12 | $1.17 | 34.29 |
| 2016-09-30 | 38.83 | $1.16 | 33.47 |
| 2016-06-30 | 34.60 | $0.92 | 37.61 |
| 2016-03-31 | 34.50 | $0.72 | 47.92 |
| 2015-12-31 | 38.69 | $0.65 | 59.52 |
| 2015-09-30 | 39.13 | $0.46 | 85.07 |
| 2015-06-30 | 38.06 | $0.47 | 80.98 |
| 2015-03-31 | 33.03 | $0.41 | 80.55 |
| 2014-12-31 | 26.74 | $0.18 | 148.56 |
| 2014-09-30 | 24.33 | $0.06 | 405.50 |
| 2014-06-30 | 25.35 | $-4.15 | 0.00 |
| 2014-03-31 | 21.50 | $-4.23 | 0.00 |
| 2013-12-31 | 22.35 | $-4.36 | 0.00 |
| 2013-09-30 | 20.65 | $-4.33 | 0.00 |
| 2013-06-30 | 19.30 | $-0.51 | 0.00 |
| 2013-03-31 | 22.60 | $-0.38 | 0.00 |
| 2012-12-31 | 20.01 | $-0.34 | 0.00 |
| 2012-09-30 | 20.22 | $-0.27 | 0.00 |
| 2012-06-30 | 18.04 | $0.12 | 150.33 |
| 2012-03-31 | 21.55 | $0.17 | 126.76 |
| 2011-12-31 | 17.51 | $0.63 | 27.79 |
| 2011-09-30 | 15.21 | $0.59 | 25.78 |
| 2011-06-30 | 20.17 | $-0.04 | 0.00 |
| 2011-03-31 | 22.20 | $-0.08 | 0.00 |
| 2010-12-31 | 18.82 | $-0.31 | 0.00 |
| 2010-09-30 | 16.01 | $-0.25 | 0.00 |
| 2010-06-30 | 13.93 | $0.41 | 33.98 |
| 2010-03-31 | 18.54 | $0.47 | 39.45 |
| 2009-12-31 | 14.50 | $-8.58 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $15.122B | $4.030B |
| Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $174.604B | 21.12 |
| Intuitive Surgical (ISRG) | United States | $169.147B | 70.11 |
| IDEXX Laboratories (IDXX) | United States | $52.172B | 54.30 |
| Edwards Lifesciences (EW) | United States | $45.888B | 30.41 |
| Alcon (ALC) | Switzerland | $41.768B | 28.23 |
| IQVIA Holdings (IQV) | United States | $30.615B | 17.30 |
| DexCom (DXCM) | United States | $30.529B | 45.79 |
| Mettler-Toledo (MTD) | United States | $25.882B | 30.72 |
| STERIS (STE) | Ireland | $23.797B | 25.33 |
| Waters (WAT) | United States | $16.625B | 22.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.421B | 0.00 |
| Penumbra (PEN) | United States | $9.340B | 68.23 |
| Sysmex ADR (SSMXY) | Japan | $8.668B | 27.54 |
| Globus Medical (GMED) | United States | $8.046B | 18.51 |
| Masimo (MASI) | United States | $8.006B | 26.94 |
| Teleflex (TFX) | United States | $5.124B | 8.27 |
| Glaukos (GKOS) | United States | $4.991B | 0.00 |
| TransMedics (TMDX) | United States | $4.338B | 65.94 |
| Integer Holdings (ITGR) | United States | $3.693B | 18.43 |
| LivaNova (LIVN) | United Kingdom | $2.706B | 15.49 |
| Alphatec Holdings (ATEC) | United States | $2.267B | 0.00 |
| Veracyte (VCYT) | United States | $2.202B | 30.42 |
| PROCEPT BioRobotics (PRCT) | United States | $2.157B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Artivion (AORT) | United States | $2.027B | 102.29 |
| Elekta AB (EKTAY) | Sweden | $1.853B | 16.66 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.001B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.993B | 5.69 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.683B | 0.00 |
| SiBone (SIBN) | United States | $0.664B | 0.00 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.522B | 4.20 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.488B | 8.62 |
| OrthoPediatrics (KIDS) | United States | $0.472B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.404B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 87.58 |
| AngioDynamics (ANGO) | United States | $0.343B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.333B | 8.46 |
| Alpha Tau Medical (DRTS) | Israel | $0.302B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.292B | 0.00 |
| RxSight (RXST) | United States | $0.272B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.271B | 18.72 |
| Neuronetics (STIM) | United States | $0.259B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.76 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |